Priority 3 from the Mesothelioma PSP
| UNCERTAINTY: What is the best way to monitor patients with diffuse pleural thickening and a negative biopsy who are considered to have a high risk of developing mesothelioma (e.g. repeat biopsies, imaging, etc)? (JLA PSP Priority 3) | |
|---|---|
| Overall ranking | 3 |
| JLA question ID | 0025/3 |
| Explanatory note | Not available for this PSP |
| Evidence | No systematic reviews or studies identified |
| Health Research Classification System category | Cancer |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples | Should the clinicians perform biopsies at various time points if one biopsy result shows pleural thickening and fibrosis only? |
| Comparison | Diagnostics |
| Submitted by | Health professional |
| Outcomes to be measured | Diagnosis |
| PSP information | |
|---|---|
| PSP unique ID | 0025 |
| PSP name | Mesothelioma |
| Total number of uncertainties identified by this PSP. | 53 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
| Date of priority setting workshop | 16 December 2014 |